Syndax Pharmaceuticals Inc (NASDAQ:SNDX) price on current trading day, rose 6.59% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $13.98.
A look at the stock’s price movement, the level at last check in today’s session was $13.12, moving within a range at $13.05 and $14.02. The beta value (5-Year monthly) was 0.923. Turning to its 52-week performance, $25.07 and $12.06 were the 52-week high and 52-week low respectively. Overall, SNDX moved -5.19% over the past month.
Syndax Pharmaceuticals Inc’s market cap currently stands at around $1.20 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
Analysts have a consensus estimate of 15.88M for the company’s revenue for the quarter, with a low and high estimate of 7.5M and 36.6M respectively. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 88.98M, representing a 275.78% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SNDX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend SNDX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SNDX’s current price about -1.27% and -1.65% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.17, while 7-day volatility ratio is 4.27% and 6.08% in the 30-day chart. Further, Syndax Pharmaceuticals Inc (SNDX) has a beta value of 1.25, and an average true range (ATR) of 0.79. Analysts have given the company’s stock an average 52-week price target of $27.5, forecast between a low of $18 and high of $37. Looking at the price targets, the low is -28.76% off recent price level in today’s trading while to achieve the yearly target high, it has to move -164.66%. Nonetheless, investors will most likely welcome a -96.71% jump to $27.5 which is the analysts’ median price.
If we refocus on Syndax Pharmaceuticals Inc (NASDAQ:SNDX), historical trading data shows that trading volumes averaged 1.66 over the past 10 days and 2.34 million over the past 3 months. The company’s latest data on shares outstanding shows there are 85.69 million shares.
The 2.18% of Syndax Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 111.94% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 19.2 million on 2025-02-28, giving us a short ratio of 7.85. The data shows that as of 2025-02-28 short interest in Syndax Pharmaceuticals Inc (SNDX) stood at 2251.0 of shares outstanding, with shares short falling to 22.2 million registered in 2025-01-31. Current price change has pushed the stock 5.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SNDX stock continues to rise going into the next quarter.
